Skip to content

The Effect of Warmed Parenteral Fluids During Delivery

The Effect of Warmed Parenteral Fluids During Vaginal Delivery and Cesarean Section

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03178461
Enrollment
7000
Registered
2017-06-07
Start date
2017-07-01
Completion date
2019-12-30
Last updated
2019-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delivery, Obstetric

Keywords

Caesarean Section, Delivery

Brief summary

To evaluate the influence of warm IV fluids during delivery and cesarean section on perinatal outcomes.

Detailed description

Prospective randomized controlled trial. Assessing the influence of warmed parenteral fluids during delivery/cesarean section on the obstetrical and neonatal outcome. The investigators will randomize parturients during the active phase of labor to receive either body temperature warmed parenteral fluids or room temperature parenteral fluids. Both groups will receive the same fluid composition of 5% dextrose with normal saline. The investigators will compare the obstetrical and neonatal outcomes of the two groups.

Interventions

OTHERBody temperature parenteral fluids

2 study groups shall receive the same parenteral fluids but at different temperatures.

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Randomization two 2 groups according to temperature of IV fluids. One group will receive room temperature fluids and the other group will receive body temperature fluids.

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Singleton pregnancies * term pregnancies * receiving parenteral fluids

Exclusion criteria

* high order pregnancies * preterm pregnancies (before 37 weeks of gestation) * known fetal major anomaly * known fetal significant chromosomal/genetic abnormality

Design outcomes

Primary

MeasureTime frameDescription
Length of the second stage of laborup to 5 hours from complete cervical dilationHow much time did it take from complete cervical dilation to the delivery of the baby.

Secondary

MeasureTime frameDescription
Prevalence of perineal tears and episiotomiesimmediately after vaginal birthThe prevalence of perineal tears and episiotomies that occurred during vaginal delivery
Neonatal APGAR scoreup to 5 minutes from deliveryComparison of the 1 minute and 5 minute APGAR score that the neonates received, between the groups.
The rate of prolonged second stageimmediately after completion of the delivery.The percentage of patients, in each group, that were defined with a prolonged second stage. The definition is more than 2 hours from complete cervical dilation until delivery of the baby in multipara patients and more than 3 hours from complete cervical dilation until delivery of the baby in nullipara patients.

Countries

Israel

Contacts

Primary ContactHanoch Schreiber, MD
hanoch.schreiber@clalit.org.il972-53-332-3248
Backup ContactTal Weissbach, MD
ferbyt@gmail.com972-546-250-299

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026